More than 1,100 hospitals across the country are stepping up pressure on HHS Secretary Alex Azar to stop drug makers from limiting 340B discounts via contract pharmacies or tying those discounts to claims data submissions, telling Azar in a letter Thursday (Sept. 10) that the manufacturers are taking away discounts on some of the costliest cancer and diabetes drugs. The hospitals’ letter doesn’t mention legal action, but 340B Health, as well as the American Hospital Association and community health centers,...